Related Experiment Videos
Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease
A Caenazzo1, F Pietrogrande, G Polato
1University of Padua Medical School, Institute of Medical Semeiotics, Italy.
Abstract:
Platelet-derived growth factor (PDGF) is thought to take part in the genesis of bone marrow fibrosis that can be found in patients with myeloproliferative diseases. We evaluated platelet mitogenic activity as the difference between serum and plasma activity in 8 patients with myeloproliferative disease. We observed a trend of lower values in 2 cases of polycythemia vera and 2 cases of essential thrombocythemia, as seen by other authors. Two patients suffering from chronic myeloid leukemia were within the normal range. In contrast, our 2 cases of idiopathic myelofibrosis showed increased levels. If confirmed by further studies, this could suggest a pathogenetic relationship between increased levels of PDGF and bone marrow fibrosis, and give differential diagnostic significance to the PDGF mitogenic assay in myeloproliferative diseases.
Insights
Platelet-derived growth factor (PDGF) may play a role in bone marrow fibrosis. This study found higher PDGF levels in idiopathic myelofibrosis patients, suggesting a diagnostic marker for myeloproliferative diseases.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Myeloproliferative diseases are associated with bone marrow fibrosis.
- Platelet-derived growth factor (PDGF) is implicated in fibrosis pathogenesis.
Purpose of the Study:
- To evaluate platelet mitogenic activity, a measure of PDGF, in patients with myeloproliferative diseases.
- To explore the potential role of PDGF in the development of bone marrow fibrosis.
Main Methods:
- Assessed platelet mitogenic activity by measuring the difference between serum and plasma PDGF activity.
- Studied 8 patients diagnosed with various myeloproliferative diseases.
Main Results:
- Observed a trend of lower PDGF activity in polycythemia vera and essential thrombocythemia.
- Found normal PDGF activity in chronic myeloid leukemia patients.
- Identified increased PDGF activity in idiopathic myelofibrosis cases.
Conclusions:
- Elevated PDGF levels may correlate with bone marrow fibrosis in myeloproliferative diseases.
- The PDGF mitogenic assay could offer differential diagnostic value for myeloproliferative diseases.